BioMarin Pharmaceutical Inc. (BMRN) Likely to Get EU Approval of Voxzogo in Next 10 Days, Opening a $4.4B Opportunity - Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 57.49 +1.49 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.00 | 52 Week High | $108.96 | |||
| Open | $56.58 | 52 Week Low | $62.12 | |||
| Day High | $57.51 | P/E | N/A | |||
| Day Low | $56.29 | EPS | $-1.27 | |||
| Volume | 2,617,630 | |||||
